EEF2K and cancer: In these studies, either suppression of eEF2K activity by its inhibitors, or genetic ablation of eEF2K, effectively slowed down cancer cell migration or invasion [55,76,77] and/or significantly prevented tumour growth in xenograft animal models [54,55,77].